Endpoints News

Otsuka buys Transcend Therapeutics for $700M upfront

Published

2 weeks ago

on

Otsuka is buying neuropsychiatric drugmaker Transcend Therapeutics in a deal worth roughly $1.2 billion, further bolstering a class of drugs that are supposed to provide the therapeutic benefits of psychedelics without the trip.

As part …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version